Molecular regulation underlying differentiation of dental pulp stem cells

牙髓干细胞分化的分子调控

基本信息

  • 批准号:
    8812561
  • 负责人:
  • 金额:
    $ 36.22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-09-01 至 2020-06-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Utilization of stem cells to repair diseased or damaged tissues/organs represents a novel approach for remedies in regenerative medicine. Although embryonic stem cells (ESC) and induced pluripotent stem cells (iPS) have been studied, there are major drawbacks and concerns in using ESC and iPS; for example, tumorigenesis and teratomas formation can occur after their transplantation. It is not clear if the obstacles pertaining to ESC and iPS can be overcome in order to use them for therapeutics; at least there is still long way to go. In contrast, adult stem cells (AdSC) are used for treatment of human diseases. One example is the transplantation of bone marrow stem cells to cure or improve certain disorders, such as leukemia. Such cell- based therapies usually require large numbers of stem cells. Because AdSC lose their stem cell properties (stemness) including differentiation capability when cultured in vitro, primary isolated AdSC can only be used for limited passages, and propagation of a large quantity of high-potential stem cells from primary isolation is difficult. Thus, large amounts of tissues are needed for stem cell isolation, and continuous isolation of AdSC is required for multiple treatments. However, tissues, e.g., dental tissues that can be used for AdSC isolation are often limited. Stem cells isolated from dental pulp of extracted and exfoliated teeth have been shown to be a good source of stem cells for regenerative medicine. However, like other AdSC, these dental pulp stem cells (DPSCs) also lose their differentiation potential when cultured in vitro, which hampers their applications. The long-term goal of this research is to elucidate the genes and molecules regulating differentiation capability in the DPSCs. Preliminary studies showed that heat shock protein B8 (HspB8) was downregulated in cultured DPSCs when the cells lost differentiation capability, and knockdown of HspB8 expression in the early passage DPSCs caused the cells to lose differentiation capability. Further studies suggested that microRNAs (miRNAs) are responsible for downregulation of HspB8 expression in DPSCs. The central hypothesis is that upregulated expression of certain miRNAs in late passage DPSCs downregulates HspB8 and other regulatory genes, and in turn causes DPSCs to lose differentiation capability during in vitro culture. The project Aims: (1) to identify the miRNAs whose expression is substantially increased in late passage DPSCs, designated as late-passage upregulated miRNAs (LPU-miRNAs); (2) to identify the LPU-miRNAs that downregulate HspB8 expression; i.e., HspB8-targeting miRNAs, and (3) to study the effects of LPU-miRNAs and HspB8-targeting miRNAs on DPSC differentiation and on regulating other potential genes. Accomplishment of the Aims would be significant in understanding the roles of miRNAs and HspB8 in regulating the loss of differentiation seen in the long-term cultured DPSCs and will shed light on other AdSC as well. This would facilitate the development of cutting- edge methods for maintaining the stem cell properties in culturing DPSCs and AdSC, such that a large quantity of stem cells with high-differentiation potential can be obtained from expansion of primary isolated stem cells.
 描述(由申请人提供):利用干细胞修复患病或受损的组织/器官代表了再生医学中的一种新的治疗方法。使用 ESC 和 iPS 的主要缺点和担忧;例如,移植后可能会发生肿瘤和畸胎瘤,目前尚不清楚。 ESC和iPS的障碍可以克服,以便将它们用于治疗;相比之下,成体干细胞(AdSC)用于治疗有很长的路要走。 一个例子是移植骨髓干细胞来治疗或改善某些疾病,例如白血病,这种基于细胞的疗法通常需要大量的干细胞,因为 AdSC 会失去其干细胞特性(干细胞特性),包括分化能力。体外培养时,原代分离的AdSC只能用于有限的传代,并且原代分离的大量高潜能干细胞的增殖是困难的,因此需要大量的组织进行干细胞分离和连续分离。 AdSC 的值为然而,可用于 AdSC 分离的组织(例如牙组织)通常是有限的,从拔牙和脱落牙齿的牙髓中分离的干细胞已被证明是再生医学干细胞的良好来源。然而,与其他AdSCs一样,这些牙髓干细胞(DPSCs)在体外培养时也会失去分化潜力,这阻碍了它们的应用。这项研究的长期目标是阐明调节分化能力的基因和分子。初步研究表明,当细胞失去分化能力时,培养的DPSCs中热休克蛋白B8(HspB8)表达下调,并且早期传代DPSCs中HspB8表达的敲低导致细胞失去分化能力。 )负责 DPSC 中 HspB8 表达的下调。核心假设是,晚期 DPSC 中某些 miRNA 的表达上调会下调 HspB8 和项目目的:(1)鉴定在晚期传代DPSC中表达显着增加的miRNA,称为晚期传代上调miRNA(LPU-miRNA)。 ); (2) 鉴定下调 HspB8 表达的 LPU-miRNA,即 HspB8 靶向 miRNA,以及 (3) 研究LPU-miRNA 和 HspB8 靶向 miRNA 对 DPSC 分化和调节其他潜在基因的作用对于理解 miRNA 和 HspB8 在调节长期培养的 DPSC 中观察到的分化丧失的作用具有重要意义。这也将有助于开发在培养 DPSC 和 AdSC 时保持干细胞特性的尖端方法,从而获得大量干细胞。高分化潜能可以通过原代分离干细胞的扩增获得。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Expression of microRNAs targeting heat shock protein B8 during in vitro expansion of dental pulp stem cells in regulating osteogenic differentiation.
  • DOI:
    10.1016/j.archoralbio.2019.104485
  • 发表时间:
    2019-11
  • 期刊:
  • 影响因子:
    3
  • 作者:
    S. Yao;Chunhong Li;Angelle M Budenski;P-A Li;A. Ramos;Steven Guo
  • 通讯作者:
    S. Yao;Chunhong Li;Angelle M Budenski;P-A Li;A. Ramos;Steven Guo
MicroRNA biogenesis and their functions in regulating stem cell potency and differentiation.
Increased Expression of miR-7a-5p and miR-592 during Expansion of Rat Dental Pulp Stem Cells and Their Implication in Osteogenic Differentiation.
  • DOI:
    10.1159/000519600
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Rong W;Rome C;Yao S
  • 通讯作者:
    Yao S
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Shaomian Yao其他文献

Shaomian Yao的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Shaomian Yao', 18)}}的其他基金

Molecular basis for the loss of differentiation capability in human bone marrow stem cells during expansion
人骨髓干细胞扩增过程中分化能力丧失的分子基础
  • 批准号:
    10057914
  • 财政年份:
    2020
  • 资助金额:
    $ 36.22万
  • 项目类别:
Molecular basis for the loss of differentiation capability in human bone marrow stem cells during expansion
人骨髓干细胞扩增过程中分化能力丧失的分子基础
  • 批准号:
    10240719
  • 财政年份:
    2020
  • 资助金额:
    $ 36.22万
  • 项目类别:
Development of selection techniques for purifying stem cells from dental tissues
开发从牙组织中纯化干细胞的选择技术
  • 批准号:
    7588220
  • 财政年份:
    2009
  • 资助金额:
    $ 36.22万
  • 项目类别:
Development of selection techniques for purifying stem cells from dental tissues
开发从牙组织中纯化干细胞的选择技术
  • 批准号:
    7784538
  • 财政年份:
    2009
  • 资助金额:
    $ 36.22万
  • 项目类别:
Molecular Basis of Tooth Eruption
牙齿萌出的分子基础
  • 批准号:
    8277789
  • 财政年份:
    1991
  • 资助金额:
    $ 36.22万
  • 项目类别:

相似海外基金

The mechanism of CELF1 upregulation and its role in the pathogenesis of Myotonic Dystrophy Type 1
CELF1上调机制及其在强直性肌营养不良1型发病机制中的作用
  • 批准号:
    10752274
  • 财政年份:
    2024
  • 资助金额:
    $ 36.22万
  • 项目类别:
Activity-Dependent Regulation of CaMKII and Synaptic Plasticity
CaMKII 和突触可塑性的活动依赖性调节
  • 批准号:
    10817516
  • 财政年份:
    2023
  • 资助金额:
    $ 36.22万
  • 项目类别:
Genetic and pharmacologic elimination of myotonia from myotonic dystrophy type 1
通过遗传和药物消除 1 型强直性肌营养不良引起的肌强直
  • 批准号:
    10750357
  • 财政年份:
    2023
  • 资助金额:
    $ 36.22万
  • 项目类别:
Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma
了解淋巴瘤对蛋白精氨酸甲基转移酶抑制剂的耐药机制
  • 批准号:
    10668754
  • 财政年份:
    2023
  • 资助金额:
    $ 36.22万
  • 项目类别:
Potentials of Epigenetic Molecules in Attenuating the Phenotypes of Periodontitis
表观遗传分子减轻牙周炎表型的潜力
  • 批准号:
    10736171
  • 财政年份:
    2023
  • 资助金额:
    $ 36.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了